A study for GSK3862995B in healthy participants and participants with Chronic Obstructive Pulmonary Disease
221531
Phase 1 other active
Quick answer
A study for GSK3862995B in healthy participants and participants with Chronic Obstructive Pulmonary Disease for Pulmonary Disease, Chronic Obstructive is a Phase 1 program (other) at GlaxoSmithKline Biologicals S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline Biologicals S.A.
- Indication
- Pulmonary Disease, Chronic Obstructive
- Phase
- Phase 1
- Modality
- other
- Status
- active